Aug 25 (Reuters) - ExpreS2ion Biotech Holding AB
EXPRS2.ST :
* EXPRES2ION ANNOUNCES UP TO SEK 216 MILLION CAPITAL RAISE
THROUGH
A FULLY GUARANTEED RIGHTS ISSUE TO FINANCE GROUND BREAKING
VACCINE AND IMMUNOTHERAPY PIPELINE
* UPON FULL SUBSCRIPTION OF RIGHTS ISSUE, COMPANY WILL
RECEIVE
APPROX. SEK 131 MILLION AND UPON FULL EXERCISE OF WARRANTS,
COMPANY WILL RECEIVE UP TO AN ADDITIONAL APPROX. SEK 85 MILLION
BEFORE DEDUCTION OF COSTS
* PROCEEDS FROM OFFERING ALLOWS COMPANY TO CONTINUE ITS
PARTICIPATION IN PREVENT-NCOV CONSORTIUM TO DEVELOP A NOVEL
COVID-19 VACCINE
* RIGHTS ISSUE COMPRISES OF A TOTAL OF 10,910,594 NEW
SHARES.
* SUBSCRIPTION PRICE IS SEK 24 PER UNIT
Source text for Eikon: ID:nWkr9tvjcK
Further company coverage: EXPRS2.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))